Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma - Yan, Qing; Lin, Hao-Ming; Zhu, Ke; Cao, Yi; Xu, Xiao-Lin; Zhou, Zi-Yu; Xu, Lei-bo; Liu, Chao; Zhang, Rui (Frontiers in oncology, 2022)
Keywords: circulating tumor cells; clinical application; FGL1; hepatocellular carcinoma (HCC); immunotherapy; Oncology; hepatocellular carcinoma (HCC); clinical application; circulating tumor cells; FGL1; immunotherapy